Mcl-1 modulating compounds for cancer treatment
US10307410B2 · kind B2 · utility
1Cited by
3References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 3, 2015 |
| Grant date | Jun 4, 2019 |
| Priority date | — |
| Expiry date | Mar 3, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.